The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel epigenomic liquid biopsy assay to predict estrogen receptor (ER) status and to infer ER pathway activation in breast cancer.
 
Stefania Morganti
Honoraria - Remedy Health; WebMD/Medscape
Travel, Accommodations, Expenses - AstraZeneca; Menarini
 
Jonathan Beagan
Employment - Precede Bio
Stock and Other Ownership Interests - Precede Bio
Travel, Accommodations, Expenses - Precede Bio
 
Anthony D'Ippolito
Employment - Kymera; Precede Bio; Syros Pharmaceuticals
Stock and Other Ownership Interests - Syros Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Precede Bio; Syros Pharmaceuticals
 
Kalie Smith
No Relationships to Disclose
 
Melissa E. Hughes
No Relationships to Disclose
 
Juliann Chmielecki
Employment - AstraZeneca; Precede Bio
Stock and Other Ownership Interests - AstraZeneca; Precede Bio
Consulting or Advisory Role - Precede Bio
 
Aparna Gorthi
Employment - Precede Bio
Stock and Other Ownership Interests - Precede Bio
 
Corrie Painter
Employment - Precede Bio
Stock and Other Ownership Interests - Precede Bio
Consulting or Advisory Role - One Health Company; Precede Bio
 
J. Carl Barrett
Employment - AstraZeneca; Precede Bio
Leadership - SAGA Diagnostics
Stock and Other Ownership Interests - AstraZeneca; Corsita; Nexosomes; Precede Bio
Consulting or Advisory Role - Agilent; Akoya Biosciences; Bian Capital; Exai Bio; Leica Biosystems; MultiplexDX
 
Matthew L Eaton
Employment - Precede Bio; Syros Pharmaceuticals; Vor Biopharma (I)
Stock and Other Ownership Interests - Precede Bio; Syros Pharmaceuticals; Tome Biosciences (I); Vor Biopharma (I)
 
Matthew Freedman
Stock and Other Ownership Interests - Precede Bio
Consulting or Advisory Role - Precede Bio
Patents, Royalties, Other Intellectual Property - A pending patent has been filed for detecting neuroendocrine prostate cancer using DNA methylation
 
Sara M. Tolaney
Consulting or Advisory Role - AADi; ARC Therapeutics; Artios Biopharmaceuticals; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Blueprint Medicines; Bristol-Myers Squibb; CytomX Therapeutics; Daiichi Sankyo; eFFECTOR Therapeutics; Eisai; Genentech; Hengrui Pharmaceutical (USA); Immunomedics/Gilead; Incyte; Infinity Pharmaceuticals; Jazz Pharmaceuticals; Lilly; Menarini Group; Merck; Natera; Novartis; OncXerna Therapeutics; Pfizer; Reveal Genomics; Sanofi; Seagen; Sumitovant Biopharma; Systimmune; Tango Therapeutics; Umoja Biopharma; Zentalis; Zetagen; Zymeworks
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); OncoPep (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Sanofi
 
Nancy U. Lin
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Artera; AstraZeneca; Blueprint Medicines; Daiichi Sankyo; Eisai; Johnson & Johnson/Janssen; Menarini; Olema Pharmaceuticals; Pfizer; Seagen
Research Funding - Genentech (Inst); Merck (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett
Travel, Accommodations, Expenses - Olema Pharmaceuticals
 
Heather Anne Parsons
Honoraria - Guardant Health
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi Sankyo/UCB Japan; Natera; SAGA Diagnostics; Sermonix Pharmaceuticals
Research Funding - GlaxoSmithKline (Inst); Merck (Inst); Seagen (Inst)
(OPTIONAL) Uncompensated Relationships - NeoGenomics Laboratories; SAGA Diagnostics